Boston Scientific Corporation (NYSE:BSX) changes shares on Tuesday trading session, with a change of -2.24% or -$0.85 shares. The trading starts at $37.78 and closed at $38.00 throughout the day. The trading session low price was $37.08 and day high was $37.99 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 7.75 million while its average volume is 10.80M. In other hand, the BSX market cap reached to $53.59B. While, its current target price is $45.78.
On July 29, 2020, Boston Scientific sees improved July trends as elective surgery recovers. According to the news reported on Reuters, Medical device maker Boston Scientific Corp
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -2.93% and up 4.38% for month. Its quarterly performance was 0.92% above, while its half year performance is down -13.36%. BSX yearly performance stood at negative -10.18% and fall -17.85% for year-to-date. Current recommendation for Boston Scientific Corporation is 1.60.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. BSX EPS (TTM) for 12-month is -0.09. EPS for this year is -63.00%, while for the next year its value is 1.66. Its EPS Q/Q reached -97.40%. It has an EPS of 46.40% up for past five years and for the next five years will be up 7.82%.
Let’s take a look on the analyst recommendations on BSX for the current month and previous month. For the current month, 22 of 26 analysts recommend stock as Buy while 0 as Sell, 1 as overweight, 1 as underweight and 2 as Hold. As compared with the previous month ratings, 26 analysts participate in stock recommendation. Out of 26, 0 rated it sell, 22 rated it as Buy and 2 as Hold Ratings. On the other hand, target price ranges from $41.00 – $50.00. Average target price for BSX was reached at $45.78.
Vanguard Group, Inc. (The), Blackrock Inc. and FMR, LLC are the top three holders in Boston Scientific Corporation (BSX) stock. On Mar 30, 2020, Vanguard Group, Inc. (The) has 111.73 million shares which valued 3.65 billion. On Mar 30, 2020, Blackrock Inc. owned 106.7 million shares which valued at 3.48 billion. On Mar 30, 2020, FMR, LLC has a total of 102.94 million shares which valued at 3.36 billion. In the end, FMR, LLC have 7.36% shares outstanding of Boston Scientific Corporation (BSX) on Mar 30, 2020. The insider ownership moved to 0.30% and institutional holding shifted to 92.80%.
The company posted an EPS (TTM) of -0.09. According to the most recent quarter report on (Sep 2020), 20 analysts estimated an average EPS of 0.24, while 0.39 EPS posted a year ago period. Analyst Estimated EPS for BSX published in the report was $0.11 – $0.32 during the same period. Comparing with last year, the average estimated EPS was 0.39 which is higher than 0.08 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for BSX fall -4.11% for period of 200 days. SMA for 50 days was 1.39% which is showing green signal, while SMA-20 was 0.29%. The moving average value for Boston Scientific Corporation (BSX) is 36.78 and 36.40 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in BSX stock. On Aug 03, Pierce David A, EVP Pres MedSurg, sold 2,385 trading shares at the cost of $38.69, which valued at 92276.0. On Jul 22, Pierce David A, EVP Pres MedSurg, sold 2,170 shares at the cost of $38.00, with total shares of 9,401. On Jun 03, Pierce David A, EVP Pres MedSurg, sold 1,624 shares at the cost of 38.00. After this transaction, Pierce David A total shares reached to 11,571 which valued at 61712.0.